Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Genes and Development

Volumn 12, Issue 9, 1998, Pages 1260-1268

  Bucay, Nathan ^a   Sarosi, Ildiko ^a   Dunstan, Colin R ^a   Morony, Sean ^a   Tarpley, John ^a   Capparelli, Casey ^a   Scully, Sheila ^a   Tan, Hong Lin ^a   Xu, Weilong ^a   Lacey, David L ^a   Boyle, William J ^a   Simonet, W Scott ^a  

^a AMGEN INC   (United States)

Author keywords

Arterial calcification; Knockout mice; Osteoporosis; Osteoprotegerin

Indexed keywords

GENE PRODUCT; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CALCIFICATION; ARTICLE; BONE DENSITY; CONTROLLED STUDY; CORTICAL BONE; FEMALE; GENE TARGETING; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN SECRETION; RENAL ARTERY; SKULL FRACTURE; TUNICA MEDIA;

ANIMALIA;

EID: 0032079445     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.9.1260     Document Type: Article

References (38)

1. Banks, L.M., J.E. Macsweeney, and J.C. Stevenson. 1994. Effect of degenerative spinal and aortic calcification on bone density measurements in postmenopausal women: Links between osteoporosis and cardiovascular disease? Eur. J. Clin. Invest. 24: 813-817.
2. Beamer, W.G., L.R. Donahue, C.J. Rosen, and D.J. Baylink. 1996. Genetic variability in adult bone density among inbred strains of mice. Bone 18: 397-403.
3. Bostrom, K., K.E. Watson, S. Horn, C. Wortham, I.M. Herman, and L.L. Demer. 1993. Bone morphogenetic protein expression in human atherosclerotic lesions. J. Clin. Invest. 91: 1800-1809.
4. Bostrom, K., K.E. Watson, W.P. Stanford, and L.L. Demer. 1995. Atheroclerotic calcification: Relation to developmental osteogenesis. Am. J. Cardiol. 75: 88B-91B.
5. Bunting, C.H. 1906. The formation of true bone with cellular (red) marrow in a sclerotic aorta. J. Exp. Med. 8: 365-376.
6. De La Mata, J., H.L. Uy, T.A. Guise, B. Story, B.F. Boyce, G.R. Mundy, and G.D. Roodman. 1995. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J. Clin. Invest. 95: 2846-2852.
7. Demer, L.L. 1995. A skeleton in the atherosclerosis closet. Circulation 92: 2029-2032.
8. Erlebacher, A. and R. Derynck. 1996. Increased expression of TGF-β2 in osteoblasts results in an osteoporosis-like phenotype. J. Cell Biol. 132: 195-210.
9. Erlebacher, A., E.H. Filvaroff, S.E. Gitelman, and R. Derynck. 1995. Toward a molecular understanding of skeletal development. Cell 80: 371-378.
10. Giachelli, C.M., N. Bae, M. Almeida, D.T. Denhardt, C.E. Alpers, and S.M. Schwartz. 1993. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J. Clin. Invest. 92: 1686-1696.
11. Girasole, G., G. Passeri, R.L. Jilka, and S.C. Manolagas. 1994. Interleukin-11: A new cytokine critical for osteoclast development. J. Clin. Invest. 93: 1516-1524.
12. Haust, M.D. and J.C. Geer. 1970. Mechanism of calcification in spontaneous aortic arteriosclerotic lesions of the rabbit: an electron microscopic study. Am. J. Pathol. 60: 329-346.
13. Hughes, D.E., A. Dai, J.C. Tiffee, H.H. Li, G.R. Mundy, and B.F. Boyce. 1996. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nature Medicine 2: 1132-1136.
14. Jilka, R.L., G. Hangoc, G. Girasole, G. Passen, D.C. Williams, J.S. Abrams, B. Boyce, H. Broxmeyer, and S.C. Manolagas. 1992. Increased osteoclast development after estrogen loss: mediation by IL-6. Science 257: 88-91.
15. Kitazawa, R., R.B. Kimble, J.L. Vannice, V.T. Kung, and R. Pacifici. 1994. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J. Clin. Invest. 94: 2397-2406.
16. Lacey, D.L., J.M. Erdmann, S.L. Teitelbaum, H.L. Tan, J. Ohara, and A. Shioi. 1995. Interleukin 4, Interferon-γ, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages. Endocrinology 136: 2367-2376.
17. Lewis, D.B., H.D. Liggitt, E.L. Effmann, S.T. Motley, S.L. Teitelbaum, K.J. Jepsen, S.A. Goldstein, J. Bonadio, J. Carpenter, and R.M. Perlmutter. 1993. Osteoporosis induced in mice by overproduction of interleukin 4. Proc. Natl. Acad. Sci. 90: 11618-11622.
18. Luo, G., P. Ducy, M.D. Mckee, G. J. Pinero, E. Loyer, R.R. Behringer, and G. Karsenty. 1997. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386: 78-81.
19. Manolagas, S.C. and R.L. Jilka. 1995. Bone marrow, cytokines, and bone remodeling; Emerging insights into the pathophysiology of osteoporosis. New Engl. J. Med. 332: 305-311.
20. Marks, S.C. 1997. The structural basis for bone cell biology. Acta Med. Dent. Helv. 2: 141-157.
21. Mundy, G.R. 1993a. Cytokines and growth factors in the regulation of bone remodeling. J. Bone Min. Res. 8: S505-S510.
22. _. 1993b. Role of cytokines in bone resorption. J. Cell Biochem. 53: 296-300.
23. Mundy, G.R., B. Boyce, D. Hughes, K. Wright, L. Bonewald, S. Dallas, S. Harris, N. Ghosh-Choudhury, D. Chen, C. Dunstan, E. Izbicka, and T. Yoneda. 1995. The effects of cytokines and growth factors on osteoblastic cells. Bone 17: 71S-75S.
24. O'Brien, K.D., J. Kuusisto, D.D. Reichenbach, M. Ferguson, C. Giachelli, C.E. Alpers, and C.M. Otto. 1995. Osteopontin is expressed in human aortic valvular lesions. Circulation 92: 2163-2168.
25. Pacifici, R. 1996. Estrogen, cytokines, and pathogenesis of post-menopausal osteoporosis. J. Bone Min. Res. 11: 1043-1051.
26. Parhami, F., K. Bostrom, K. Watson, and L.L. Demer. 1996. Role of molecular regulation in vascular calcification. J. Atheroscler. Thromb. 3: 90-94.
27. Parhami, F. and L.L. Demer. 1997. Arterial calcification in face of osteoporosis in ageing: Can we blame oxidized lipids? Curr. Opin. Lipidol. 8: 312-314.
28. Parhami, F., A.D. Morrow, J. Balucan, N. Leitinger, A.D. Watson, Y. Tintut, J.A. Berliner, and L.L. Demer. 1997. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation: A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler. Thromb. Vasc. Biol. 17: 680-687.
29. Qiao, J., P. Xie, M.C. Fishbein, J. Kreuzer, T.A. Drake, L.L. Demer, and A.J. Lusis. 1994. Pathology of atheromatous lesions in inbred and genetically engineered mice: Genetic determination of arterial calcification. Arterioscler. Thromb. 14: 1480-1497.
30. Roodman, G.D. 1996. Advances in bone biology: The osteoclast. Endocr. Rev. 17: 308-332.
31. Schmid, K., W.O. McSharry, C.H. Pameijer, and J.P. Binette. 1980. Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta. Atherosclerosis 37: 199-210.
32. Simonet, W.S., D.L. Lacey, C.R. Dunstan, M. Kelley, M.-S. Chang, R. Luethy, H.Q. Nguyen, S. Wooden, L. Bennett, T. Boone et al. 1997. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89: 309-319.
33. Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted Disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702.
34. Takahashi, N., T. Akatsu, N. Udagawa, T. Sasaki, A. Yamaguchi, J.M. Moseley, T.J. Martin, and T. Suda. 1988. Osteoblastic cells are involved in osteoclast formation. Endocrinology 123: 2600-2602.
35. Takahashi, T., T. Wada, M. Mori, Y. Kokai, and S. Ishii. 1996. Overexpression of the granulocyte colony stimulating factor gene leads to osteoporosis in mice. Lab. Invest. 74: 827-834.
36. Uy, H.L., T.A. Guise, J. De La Mata, S.D. Taylor, B.M. Story, M.R. Dallas, B.F. Boyce, G.R. Mundy, and G.D. Roodman. 1995. Effects of parathyroid hormone (PTH)-related protein and PTH on osteoclasts and osteoclast precursors in vivo. Endocrinology 136: 3207-3212.
37. Wang, Z.-Q., C. Ovitt, A.E. Grigoriadis, U. Moehle-Steinlein, U. Ruether, and E.F. Wagner. 1992. Bone and haematopoitic defects in mice lacking c-fos. Nature 360: 741-745.
38. Yoshida, H., S. Hayashi, T. Kunisada, M. Ogawa, S. Nishikawa, H. Okumura, T. Sudo, L.D. Shultz, and S.-I. Nishikawa. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442-444.